Crinetics Pharmaceuticals, Inc. (CRNX) financial statements (2020 and earlier)

Company profile

Business Address 10222 BARNES CANYON ROAD, BLDG. #2
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:132164
Cash and cash equivalents6745
Short-term investments65119
Other undisclosed cash, cash equivalents, and short-term investments00
Receivables01
Other current assets11
Other undisclosed current assets21
Total current assets:135167
Noncurrent Assets
Operating lease, right-of-use asset3
Property, plant and equipment44
Restricted cash and investments11
Total noncurrent assets:75
TOTAL ASSETS:143171
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities88
Accounts payable21
Accrued liabilities34
Employee-related liabilities32
Total current liabilities:88
Noncurrent Liabilities
Long-term debt and lease obligation5 
Operating lease, liability5
Liabilities, other than long-term debt03
Deferred compensation liability, classified00
Deferred rent credit 3
Total noncurrent liabilities:53
Total liabilities:1311
Stockholders' equity
Stockholders' equity attributable to parent130160
Common stock 0
Additional paid in capital 204
Accumulated other comprehensive income00
Accumulated deficit(79)(43)
Other undisclosed stockholders' equity attributable to parent209 
Total stockholders' equity:130160
TOTAL LIABILITIES AND EQUITY:143171

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
Gross profit:22
Operating expenses(50)(31)
Operating loss:(48)(29)
Nonoperating income42
Investment income, nonoperating42
Net loss available to common stockholders, diluted:(44)(27)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
Net loss:(44)(27)
Other comprehensive income00
Other undisclosed comprehensive income0 
Comprehensive loss, net of tax, attributable to parent:(44)(27)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: